CFDE Data Portal | Search TUBAP2

	Label	Description
	TUBAP2 associations Collection (Entity type)	Associations for TUBAP2_associations
	TUBAP2 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	TUBAP2 Gene (Entity type)	ENSG00000214391 - tubulin alpha pseudogene 2
	GSE146358 dopamine 3 v 7 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE151090 verteporfin 2 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE216043 cisplatin 11 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE190178 MEK CDK8 inhibition 1 v 4 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE193900 GSE193905 PURA knockdown HeLa 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE240439 decitabine 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE182150 KIT LSD1 MYC inhibition 4 v 7 human dn Gene Set (Entity type)	A Gene Set from LINCS

TUBAP2 associations

Associations for TUBAP2_associations

TUBAP2 associations.tsv

A file from IDG as part of the Harmonizome project

TUBAP2

ENSG00000214391 - tubulin alpha pseudogene 2

GSE146358 dopamine 3 v 7 human dn

A Gene Set from LINCS

GSE151090 verteporfin 2 v 1 human dn

A Gene Set from LINCS

GSE216043 cisplatin 11 v 4 human dn

A Gene Set from LINCS

GSE190178 MEK CDK8 inhibition 1 v 4 human up

A Gene Set from LINCS

GSE193900 GSE193905 PURA knockdown HeLa 1 v 0 human dn

A Gene Set from LINCS

GSE240439 decitabine 1 v 0 human dn

A Gene Set from LINCS

GSE182150 KIT LSD1 MYC inhibition 4 v 7 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.